Video

Preserving Fertility and Improving Outcomes in Breast Cancer

Halle Moore, M.D., physician at Department of Solid Tumor Oncology at Cleveland Clinic Taussig Cancer Institute, discusses fertility preservation in women with breast cancer.

Halle Moore, M.D., physician at Department of Solid Tumor Oncology at Cleveland Clinic Taussig Cancer Institute, discusses fertility preservation in women with breast cancer.

A recent study presented at the 2017 San Antonio Breast Cancer Symposium (SABCS) found that women who took goserelin, a GnRH analog that temporarily suppressed ovarian function, not only resulted in a higher rate of pregnancies, but it also improved survival outcomes, too. That particular study was presented alongside four others that also analyzed GnRH analogs in premenopausal patients with breast cancer. They, too, found that this class of drugs can be beneficial.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of 2 doctors and text.
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Image of two people.
Image of doctor.
Related Content